Claims for Patent: 8,809,629

Summary for Patent: 8,809,629

Title:	Modification of plant lignin content
Abstract:	DNA constructs comprising a first DNA segment that corresponds to at least a portion of a gene in the monolignol biosynthetic pathway, a spacer DNA segment, and a second DNA segment that is complementary to the first DNA segment can be used to reduce or modulate the lignin content in plants. In some embodiments, DNA constructs comprise at least a portion of a gene for 4CL, C3H, CCR, C4H or CCoAOMT. Vascular-preferred and constitutive promoters can be used to drive expression of the constructs.
Inventor(s):	Forster; Richard L. (Auckland, NZ), Rottmann; William H. (Summerville, SC), Connett; Marie B. (Canberra, AU), Sanders; Paul (Auckland, NZ), Zhang; Gary (Auckland, NZ), Fitzgerald; Sandra Joanne (Auckland, NZ), Eagleton; Clare (Auckland, NZ)
Assignee:	Arborgen Inc. (Ridgeville, SC)
Application Number:	13/244,018
Patent Claims:	1. A DNA construct comprising a promoter operably linked to a first DNA segment comprising at least 50 bp of a Eucalyptus grandis cinnamate 4-hydroxylase (C4H) gene sequence disclosed in SEQ ID NO: 47, an intron spacer DNA segment comprising SEQ ID NO: 9, and a second DNA segment comprising a Eucalyptus grandis cinnamate 4-hydroxylase (C4H) gene sequence disclosed in SEQ ID NO: 47 that is fully complementary to the first DNA segment, wherein the first and second DNA segments are arranged in a 5' to 3' direction with respect to each other. 2. The DNA construct of claim 1, wherein the promoter is a xylem-preferred promoter. 3. The DNA construct of claim 2, wherein the promoter is a Eucalyptus grandis Arabinogalactan Protein promoter. 4. The DNA construct of claim 1, wherein the promoter is a Pinus taeda 4CL promoter. 5. A plant cell transformed with the DNA construct of claim 1, wherein the plant cell expresses a double-stranded RNA encoded by the DNA construct. 6. A transgenic plant comprising the plant cell of claim 5, wherein expression of the double-stranded RNA in the plant results in the down-regulation of cinnamate 4-hydroxylase (C4H) gene expression involved in the monolignol biosynthetic pathway in the plant. 7. A method of reducing lignin content in a plant by inhibiting the expression of a cinnamate 4-hydroxylase (C4H) gene involved in the monolignol biosynthetic pathway in the plant, comprising transforming a plant cell with the DNA construct of claim 1, wherein the transformed plant cell expresses a double-stranded RNA encoded by the DNA construct, and culturing the transformed plant cell under conditions that promote regeneration of a transgenic plant, wherein expression of the double-stranded RNA in the plant results in the inhibition of the cinnamate 4-hydroxylase (C4H) gene expression in the plant, thereby reducing lignin content in the transformed plant.

Details for Patent 8,809,629

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2024-09-22
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2024-09-22
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2024-09-22